# Avastin for CNV Secondary to Pattern Dystrophy

> **NCT00391144** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of Trieste** · enrollment: 5 (—)

## Conditions studied

- Choroidal Neovascularization Secondary to Pattern Dystrophy

## Interventions

- **PROCEDURE:** intravitreal triamcinolone injection of avastin (1.25 mg)

## Key facts

- **NCT ID:** NCT00391144
- **Lead sponsor:** University of Trieste
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 5 (—)
- **Last updated:** 2006-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391144, "Avastin for CNV Secondary to Pattern Dystrophy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00391144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*